arrow_back Back to App

Expanded research on veteran brain injuries, including low-level blast exposure.

This Act expands the Precision Medicine for Veterans Initiative to focus specifically on brain health, dementia, and injuries resulting from repetitive low-level blast exposure. This means veterans affected by such injuries will benefit from improved diagnosis, new treatment methods (including growth hormone replacement therapy studies), and enhanced quality of care. The legislation authorizes $5 million annually through 2034 to fund this research, directly impacting the quality of life and functioning of affected veterans.
Key points
Expansion of the Veterans Precision Medicine research program to include dementia and brain injuries from repetitive low-level blast exposure.
Mandate to conduct research on clinical and non-clinical interventions and a study on using growth hormone replacement therapy to improve cognitive function in affected veterans.
Requirement for the National Academies of Sciences, Engineering, and Medicine to assist in validating brain and mental health biomarkers among veterans.
Authorization of $5 million annually for this research for fiscal years 2025 through 2034.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_5460
Sponsor: Sen. Moran, Jerry [R-KS]
Process start date: 2024-12-10
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Precision Brain Health Research Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_5460.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-12-10.

What are the main provisions?

Key points include:

  • Expansion of the Veterans Precision Medicine research program to include dementia and brain injuries from repetitive low-level blast exposure.
  • Mandate to conduct research on clinical and non-clinical interventions and a study on using growth hormone replacement therapy to improve cognitive function in affected veterans.
  • Requirement for the National Academies of Sciences, Engineering, and Medicine to assist in validating brain and mental health biomarkers among veterans.
  • Authorization of $5 million annually for this research for fiscal years 2025 through 2034.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Moran, Jerry [R-KS].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health Benefits